January 17, 2025 12:28 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'It has been an incredibly challenging day': Kareena Kapoor Khan requests privacy after Saif Ali Khan's stabbing incident | 'Distorting history': Mamata slams Mohan Bhagwat over his Ram Temple consecration 'marking true independence' remark | Saif Ali Khan stabbing incident: Actor who received six wounds is out of danger, one accused identified | ISRO creates history docking two Indian satellites in space | US-based short seller Hindenburg Research that targeted Adani Group and SEBI chairperson to be disbanded | Saif Ali Khan stabbed during burglary attempt at home, hospitalised; police probe on | Israel, Hamas reach ceasefire agreement to end 15-month-long war in Gaza | 'Ugly truth exposed': BJP slams Rahul Gandhi over his 'Opposition fighting Indian state' remark | We have a deal for hostages in Middle East: Donald Trump takes credit for Israel, Hamas ceasefire agreement | Israel, Hamas reach ceasefire agreement to end 15-month-long war in Gaza
Novavax vaccine gets first emergency use approval in Indonesia: Statement

Novavax vaccine gets first emergency use approval in Indonesia: Statement

Nov 02, 2021, at 05:45 am

Jakarta/UNI/Sputnik: US drug maker Novavax said on Monday that the Covid-19 vaccine it jointly developed with the Serum Institute of India has received the first authorization for emergency use in Indonesia.

SII to start production of Russia's Sputnik V vaccine from September

SII to start production of Russia's Sputnik V vaccine from September

Jul 13, 2021, at 08:38 pm

Pune/IBNS: World's largest vaccine manufacturer, Serum Institute of India (SII), is all set to start the production of Russia's Sputnik V vaccine in India from September, said the CEO of Russian Direct Investment Fund (RDIF), Kirill Dmitriev.

'A new milestone has been reached', says Serum Institute as it starts production of first batch of Covavax

'A new milestone has been reached', says Serum Institute as it starts production of first batch of Covavax

Jun 26, 2021, at 06:18 am

Pune/IBNS: The Serum institute of India, which started manufacturing the first batch of Novavax's Covid-19 vaccine in India under the name Covavax, said "a new milestone has been reached".

Govt's expert panel clears Oxford COVID-19 vaccine for India

Govt's expert panel clears Oxford COVID-19 vaccine for India

Jan 02, 2021, at 03:56 am

New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).

Govt's expert panel to meet over Covid-19 vaccine approval today

Govt's expert panel to meet over Covid-19 vaccine approval today

Jan 01, 2021, at 04:30 pm

New Delhi/IBNS: An expert panel, appointed by the central government, will on Friday meet over the approval for an emergency use of three Covid-19 vaccines, including an indigenous one.

Serum Institute gets DCGI nod to resume Covid-19 vaccine

Serum Institute gets DCGI nod to resume Covid-19 vaccine

Sep 16, 2020, at 04:25 pm

New Delhi/IBNS: The Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, media reports said. 

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

Sep 10, 2020, at 04:23 am

New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.